Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination
Authors:
- Athmanundh DilrajADAthmanundh Dilraj
- Reshma SukhooRSReshma Sukhoo
- Felicity T. CuttsFCFelicity T. Cutts
- John V. BennettJBJohn V. Bennett
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- First 5 years of measles elimination in southern Africa: 1996–2000The Lancet, 2002
- PERSISTENCE OF MEASLES ANTIBODY TWO YEARS AFTER REVACCINATION BY AEROSOL OR SUBCUTANEOUS ROUTESThe Pediatric Infectious Disease Journal, 2000
- Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trialThe Lancet, 2000
- Altenative Routes of Measles Immunization: a ReviewBiologicals, 1997
- Measles Elimination in the AmericasJAMA, 1996
- Measles vaccine failuresThe Pediatric Infectious Disease Journal, 1994
- Persistence of Measles Antibody after RevaccinationThe Journal of Infectious Diseases, 1992
- The 1st International Standard for anti-measles serumBiologicals, 1991
- Measles, killer of millions in developing countries: strategy for rapid elimination and continuing controlEuropean Journal of Epidemiology, 1991
- Measles RevaccinationAmerican Journal of Diseases of Children, 1978